NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

INMD

Inmode Ltd

Jul 03 • 04:00PM ET

15.16

Dollar change -0.05
Percentage change -0.33	%

Healthcare • Medical Devices • Israel • NASD

Peers: ALGN IRTC CUTR PODD NVCR HAE CERS VCEL MDXG CLGN

| Held by: IEFA VTWO IXUS SCZ IZRL PSC IDEV EIS SPDW ITEQ

Scroll to Statements

Index	-	P/E	6.52	EPS (ttm)	2.33	Insider Own	16.22%	Shs Outstand	69.56M	Perf Week	7.75%
Market Cap	1.05B	Forward P/E	8.16	EPS next Y	1.86	Insider Trans	0.00%	Shs Float	58.28M	Perf Month	3.06%
Enterprise Value	547.18M	PEG	1.30	EPS next Q	0.43	Inst Own	62.43%	Short Float	9.30%	Perf Quarter	-15.68%
Income	175.78M	P/S	2.69	EPS this Y	-4.86%	Inst Trans	2.06%	Short Ratio	3.40	Perf Half Y	-8.84%
Sales	392.41M	P/B	1.70	EPS next Y	10.96%	ROA	22.02%	Short Interest	5.42M	Perf YTD	-9.22%
Book/sh	8.91	P/C	2.06	EPS next 5Y	5.03%	ROE	24.50%	52W High	19.85 -23.63%	Perf Year	-15.17%
Cash/sh	7.37	P/FCF	8.65	EPS past 3/5Y	3.55% 16.55%	ROIC	28.12%	52W Low	13.14 15.37%	Perf 3Y	-34.60%
Dividend Est.	-	EV/EBITDA	4.94	Sales past 3/5Y	3.36% 20.35%	Gross Margin	80.03%	Volatility	3.85% 3.08%	Perf 5Y	8.36%
Dividend TTM	-	EV/Sales	1.39	EPS Y/Y TTM	9.26%	Oper. Margin	28.05%	ATR (14)	0.48	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.86	Sales Y/Y TTM	-15.84%	Profit Margin	44.80%	RSI (14)	63.35	Recom	2.86
Dividend Gr. 3/5Y	- -	Current Ratio	8.73	EPS Q/Q	-5.48%	SMA20	7.48%	Beta	1.94	Target Price	17.05
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	-9.92%	SMA50	5.07%	Rel Volume	0.37	Prev Close	15.21
Employees	599	LT Debt/Eq	0.01	Earnings	Apr 28 BMO	SMA200	-9.72%	Avg Volume	1.59M	Price	15.16
IPO	Aug 08, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-12.33% 0.45%	Trades		Volume	595,903	Change	-0.33%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-25	Downgrade	BTIG Research	Buy → Neutral
Apr-28-25	Downgrade	Robert W. Baird	Outperform → Neutral	$22 → $16
Oct-17-24	Initiated	BTIG Research	Buy	$25
Jul-23-24	Downgrade	Jefferies	Buy → Hold	$21 → $19
Nov-03-23	Downgrade	UBS	Buy → Neutral	$52 → $24
Oct-13-23	Downgrade	Canaccord Genuity	Buy → Hold	$55 → $22
Mar-29-23	Initiated	UBS	Buy	$40
Feb-17-23	Downgrade	Needham	Buy → Hold
Dec-21-22	Initiated	Barclays	Overweight	$44
Oct-12-22	Initiated	Jefferies	Buy	$40
May-25-21	Initiated	Barclays	Overweight	$92
May-18-21	Initiated	Needham	Buy	$94
Sep-03-19	Initiated	UBS	Buy	$28
Sep-03-19	Initiated	Robert W. Baird	Outperform	$27
Sep-03-19	Initiated	Canaccord Genuity	Buy	$30
Sep-03-19	Initiated	Barclays	Overweight	$27

Show Previous Ratings

May-28-25 08:30AM	InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 (PR Newswire)
May-23-25 10:26AM	Do Options Traders Know Something About InMode Stock We Don't? (Zacks)
May-20-25 09:19AM	InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology (PR Newswire)
May-09-25 08:22AM	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program (PR Newswire)
May-07-25 08:30AM	InMode to Present at Upcoming Investor Conferences and Events (PR Newswire)
08:03AM	Loading…
May-06-25 08:03AM	InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges (PR Newswire)
Apr-29-25 07:00AM	InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade) (Seeking Alpha)
05:57AM	Company News for Apr 29, 2025 (Zacks)
03:02AM	InMode Ltd (INMD) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
01:52AM	InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade) (Seeking Alpha)
Apr-28-25 11:53AM	InMode Ltd. (INMD) Q1 2025 Earnings Call Transcript (Seeking Alpha) -12.08%
08:25AM	InMode (INMD) Lags Q1 Earnings Estimates (Zacks)
07:25AM	InMode: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease (PR Newswire)
Apr-24-25 10:01AM	Earnings Preview: Envista (NVST) Q1 Earnings Expected to Decline (Zacks)
10:00AM	Loading…
Apr-21-25 10:00AM	Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline (Zacks)
Apr-14-25 07:00AM	InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M (PR Newswire)
Apr-10-25 11:36AM	InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock? (Zacks) -8.80%
Apr-03-25 04:26AM	InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade) (Seeking Alpha) -9.34%
Mar-27-25 05:00AM	HCI Group and Boise Cascade have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Mar-26-25 11:44AM	3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally (Zacks)
08:30AM	InMode to Present at the 24th Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-25-25 09:40AM	Is InMode (INMD) Stock Undervalued Right Now? (Zacks)
Mar-06-25 07:30AM	InMode Responds to Doma Perpetual's Letters (PR Newswire)
Mar-03-25 08:30AM	InMode to Present at Upcoming Investor Conferences (PR Newswire)
Feb-06-25 06:00PM	InMode (INMD) Q4 2024 Earnings Call Transcript (Motley Fool)
Feb-05-25 07:10AM	InMode Ltd (INMD) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
02:08AM	InMode Ltd (INMD) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... (GuruFocus.com)
Feb-04-25 07:16AM	InMode: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program (PR Newswire)
08:30AM	Loading…
Feb-03-25 08:30AM	InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference (PR Newswire)
Jan-29-25 09:48AM	Do Options Traders Know Something About InMode (INMD) Stock We Don't? (Zacks)
Jan-16-25 07:00AM	InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced (PR Newswire)
Jan-15-25 08:05AM	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback (PR Newswire)
Jan-08-25 07:00AM	InMode to Report Fourth Quarter and Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M (PR Newswire) -7.99%
07:00AM	InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M (PR Newswire)
Dec-10-24 10:53PM	Why Is InMode Ltd. (INMD) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey)
Nov-06-24 08:30AM	InMode to Present at Upcoming Investor Conferences (PR Newswire) +7.65%
Oct-31-24 07:29AM	InMode Sees Revenue Growth Amidst Challenges in Q3 2024 (TipRanks)
03:07AM	InMode Ltd (INMD) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments (GuruFocus.com)
01:25AM	Q3 2024 Inmode Ltd Earnings Call (Thomson Reuters StreetEvents)
Oct-30-24 03:45PM	InMode (INMD) Q3 2024 Earnings Call Transcript (Motley Fool)
08:10AM	InMode (INMD) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:07AM	InMode: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024) (PR Newswire)
Oct-29-24 09:11AM	What To Expect From InMode Ltd (INMD) Q3 2024 Earnings (GuruFocus.com)
Oct-24-24 07:03AM	InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories (PR Newswire)
Oct-23-24 10:01AM	Earnings Preview: InMode (INMD) Q3 Earnings Expected to Decline (Zacks)
Oct-14-24 09:40AM	Is InMode (INMD) a Great Value Stock Right Now? (Zacks)
Oct-13-24 05:25PM	InMode price target lowered to $27 from $29 at Barclays (TipRanks)
Oct-10-24 07:00AM	InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 (PR Newswire) +7.38%
Oct-09-24 03:42PM	InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations (GuruFocus.com)
Oct-02-24 07:28AM	InMode Restructures Amidst Global Expansion (TipRanks)
Oct-01-24 07:00AM	InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy (PR Newswire) -8.55%
Sep-26-24 09:40AM	Should Value Investors Buy InMode (INMD) Stock? (Zacks)
Sep-23-24 05:34AM	InMode (INMD): Among the Worst Middle East and Africa Stocks to Buy Now (Insider Monkey) -5.80%
Sep-10-24 09:40AM	Are Investors Undervaluing InMode (INMD) Right Now? (Zacks) +8.83%
07:00AM	InMode Announces Share Repurchase Program of Up to 7.68 Million Shares (PR Newswire)
Sep-04-24 08:30AM	InMode to Present at 2024 Baird Global Healthcare Conference (PR Newswire)
Sep-01-24 11:27PM	InMode (INMD): The Best Middle East and Africa Stocks to Buy According to Analysts? (Insider Monkey)
Aug-14-24 11:05AM	InMode Ltd. (INMD): Challenges and Insights in the Beauty Industry (Insider Monkey)
Aug-09-24 06:46AM	Why Are Analysts Bullish on InMode Ltd. (INMD) Right Now? (Insider Monkey)
Aug-06-24 08:30AM	InMode to Present at Upcoming Investor Conferences (PR Newswire)
Aug-01-24 10:30PM	InMode (INMD) Q2 2024 Earnings Call Transcript (Motley Fool) -8.55%
08:15AM	InMode (INMD) Q2 Earnings and Revenues Top Estimates (Zacks)
07:14AM	InMode: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M (PR Newswire)
Jul-31-24 08:03AM	InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform (PR Newswire)
Jul-25-24 10:02AM	Analysts Estimate InMode (INMD) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:15AM	DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer (PR Newswire)
Jul-17-24 08:03AM	Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling (PR Newswire)
Jul-11-24 08:30AM	InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024 (PR Newswire)
Jul-01-24 06:00AM	3 MedTech Stocks to Buy for Healthy Gains (InvestorPlace)
May-16-24 08:00AM	InMode to Present at Jefferies Healthcare Conference (PR Newswire)
May-08-24 08:03AM	InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand (PR Newswire)
May-03-24 12:12PM	InMode Ltd. (NASDAQ:INMD) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:41AM	UBS Adjusts Price Target on InMode to $20 From $26, Maintains Neutral Rating (MT Newswires)
May-02-24 07:15PM	InMode (INMD) Q1 2024 Earnings Call Transcript (Motley Fool)
01:31PM	InMode Shares Rise; Q1 Non-GAAP Earnings, Revenue Fall; 2024 Guidance Cut (MT Newswires)
11:55AM	INMD Stock Earnings: InMode Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:30AM	InMode (INMD) Q1 Earnings and Revenues Beat Estimates (Zacks)
08:30AM	InMode: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M; (PR Newswire)
Apr-25-24 10:01AM	Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline (Zacks)
Apr-15-24 07:00AM	InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL (PR Newswire)
05:45AM	Shareholders of InMode Ltd. Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMD (PR Newswire)
Apr-10-24 05:45AM	InMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - INMD (PR Newswire)
Apr-09-24 07:00AM	InMode to Report First Quarter 2024 Financial Results and Hold Conference Call May 2, 2024 (PR Newswire) -6.87%
Apr-03-24 06:00PM	InMode (INMD) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
08:00AM	InMode to Present at Upcoming Investor Conferences and Events (PR Newswire)
Apr-01-24 09:30AM	Is InMode (INMD) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
09:00AM	InMode Ltd. (INMD) is Attracting Investor Attention: Here is What You Should Know (Zacks)
05:45AM	InMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMD (PR Newswire)
Mar-28-24 06:00PM	Why InMode (INMD) Outpaced the Stock Market Today (Zacks)
Mar-26-24 08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
Mar-21-24 06:00PM	InMode (INMD) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Mar-19-24 09:00AM	InMode Ltd. (INMD) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-15-24 05:50PM	Why InMode (INMD) Dipped More Than Broader Market Today (Zacks)
09:30AM	Brokers Suggest Investing in InMode (INMD): Read This Before Placing a Bet (Zacks)
Mar-13-24 11:45AM	SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InMode (PR Newswire)

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INMD

Inmode Ltd

Upgrade your FINVIZ experience